<DOC>
	<DOCNO>NCT01882712</DOCNO>
	<brief_summary>The purpose study compare efficacy assess safety CD07805/47 gel 0.5 % apply topically daily 29 day versus vehicle control , subject moderate severe chronic persistent vascular facial erythema</brief_summary>
	<brief_title>Phase 3 Efficacy Safety Study CD07805/47 Topical Gel Subjects With Persistent Facial Erythema</brief_title>
	<detailed_description />
	<mesh_term>Erythema</mesh_term>
	<criteria>Male female , least 18 year age old screen visit . Presence chronic persistent vascular facial erythema ≥ 3 month history . A Clinician 's Erythema Assessment ( CEA ) score ≥3 Screening Predose ( T0 ) Baseline/Day 1 . A Patient Self Assessment ( PSA ) score ≥3 Screening Predose ( T0 ) Baseline/Day 1 . More 2 facial inflammatory lesion ( papule , pustule , nodule ) . Presence area significant scale crust face . Presence psoriatic lesion face . Presence dermatological condition face , opinion Investigator , may significantly interfere interpretation clinical trial result .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>